Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Presentation Icons
Platinum Award
Gold Award
Silver Award
Bronze Award
85 Views
Tweet
Print
Email
Infectious Diseases
(ID025) Clinical Evaluation of the Seegene Anyplex™ II MTB/MDR and Cepheid Xpert® MTB/RIF PCR assays compared to standard-of-care culture in a high-risk patient population.
Saturday, November 18, 2023
9:15 AM - 10:15 AM
MST
Speaker(s)
GH
Glen Hansen
seegene
Minneapolis, Minnesota, United States